• 1
    Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985; 312: 14651472.
  • 2
    Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991; 324: 709715.
  • 3
    Gill S, Loprinzi CL, Sargent DJ, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004; 22: 17971806.
  • 4
    National Institutes of Health. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 14441450.
  • 5
    Patwardhan MB, Fisher DA, Mantyh CR, et al. Assessing the quality of colorectal cancer care: do we have appropriate quality measures? J Eval Clin Pract. In press.
  • 6
    Institute of Medicine. Assessing the Quality of Cancer Care: An Approach to Measurement in Georgia. Committee on Assessing Improvements in Cancer Care in Georgia. National Cancer Policy Board. Washington, DC: The National Academies Press; 2005.
  • 7
    Jessup JM, McGinnis LS, Steele GDJr., Menck HR, Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer. 1996; 78: 918926.
  • 8
    Mahoney T, Kuo YH, Topilow A, Davis JM. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg. 2000; 135: 182185.
  • 9
    Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001; 93: 850857.
  • 10
    Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000; 284: 30283035.
  • 11
    Steele GD Jr. Colorectal Cancer. In: SteeleGDJr., WinchesterDP, MenckHR, MurphyGP, editors. National Cancer Data Base Annual Review of Patient Care, 1994. Atlanta, GA: American Cancer Society. 1994: 2442.
  • 12
    Steele GDJr, Jessup JM. Colorectal Cancer. In: SteeleGDJr, WinchesterDP, MenckHR, MurphyGP, editors. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta, GA: American Cancer Society. 1995: 6683.
  • 13
    Sundararajan V, Grann VR, Jacobson JS, Ahsan H, Neugut AI. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J. 2001; 7: 213218.
  • 14
    Neugut AI, Fleischauer AT, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002; 20: 26432650.
  • 15
    Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from Surveillance, Epidemiology, and End Results—Medicare. J Clin Oncol. 2001; 19: 37123718.
  • 16
    Steele GDJr. The National Cancer Data Base report on colorectal cancer. Cancer. 1994; 74: 19791989.
  • 17
    Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 12931300.
  • 18
    Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol. 2003; 83: 6878; discussion, 78–79.
  • 19
    Keating N, Landrum MB, Meara E, Ganz PGE. Do increases in the market share of managed care influence quality of care in the fee-for-service sector? J Natl Cancer Inst. 2005; 97: 257264.
  • 20
    Tropman S, Hatzell T, Paskett E, Ricketts T, Cooper M, Aldrich T. Colon cancer treatment in rural North and South Carolina. Cancer Detect Prev. 1999; 23: 428434.
  • 21
    North Central Cancer Network. Clinical practice guidelines in oncology: colon cancer. Version 3, 2005. Available at: Accessed July 7, 2005.
  • 22
    Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002; 20: 11921202.
  • 23
    Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Treatment and referral patterns for colorectal cancer. Med Care. 2004; 42: 901906.
  • 24
    Beart RW, Steele GDJr., Menck HR, Chmiel JS, Ocwieja KE, Winchester DP. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. J Am Coll Surg. 1995; 181: 225236.
  • 25
    Hyman N, Labow SB, Vermont Chapter of the American College of Surgeons. The Vermont Colorectal Cancer Project: self-portrait. Arch Surg. 2002; 137: 413416.
  • 26
    Rogers SO, Ray WA, Smalley WE. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control. 2004; 15: 193199.
  • 27
    Coburn MC, Pricolo VE, Soderberg CH. Factors affecting prognosis and management of carcinoma of the colon and rectum in patients more than eighty years of age. J Am Coll Surg. 1994; 179: 6569.
  • 28
    Coia L, Wizenberg M, Hanlon A, et al. Evaluation and treatment of patients receiving radiation for cancer of the rectum or sigmoid colon in the United States: results of the 1988–1989 Patterns of Care Study process survey. J Clin Oncol. 1994; 12: 954959.
  • 29
    Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998; 82: 23122320.
  • 30
    Wudel LJJr., Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002; 137: 550554; discussion, 554–556.
  • 31
    Govindarajan R, Shah RV, Erkman LG, Hutchins LF. Racial differences in the outcome of patients with colorectal carcinoma. Cancer. 2003; 97: 493498.
  • 32
    Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst. 1993; 85: 15801584.
  • 33
    Retchin SM, Brown B. Management of colorectal cancer in Medicare health maintenance organizations. J Gen Intern Med. 1990; 5: 110114.
  • 34
    Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Krischer JP. Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health. 2000; 90: 17461754.
  • 35
    Kline RW, Smith AR, Coia LR, et al. Treatment planning for adenocarcinoma of the rectum and sigmoid: a Patterns of Care Study. PCS Committee. Int J Radiat Oncol Biol Phys. 1997; 37: 305311.
  • 36
    Minsky BD, Coia L, Haller DG, et al. Radiation therapy for rectosigmoid and rectal cancer: results of the 1992–1994 Patterns of Care process survey. J Clin Oncol. 1998; 16: 25422547.
  • 37
    Patterns of Care Study Consensus Committee. PCS Consensus Committee: 1996 decision trees and management guidelines. Semin Radiat Oncol. 1997; 7: 163181.
  • 38
    Donaldson MS. Institute of Medicine. Measuring the quality of health care. A statement by the National Roundtable on Health Care Quality. Washington, DC: National Academy Press; 1999.
  • 39
    Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006; 24: 626634.